Maximus, Inc. (NYSE:MMS – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $62.96 and traded as low as $61.16. Maximus shares last traded at $62.00, with a volume of 845,916 shares traded.
Maximus News Summary
Investors following MMS have been watching these news items:
- Positive Sentiment: Fiscal Q4 adjusted earnings were $2.11 per share, above consensus estimates of about $1.85–$1.88 and up from $1.62 a year earlier. Maximus tops Q4 earnings estimates
- Positive Sentiment: Maximus completed its $660 million acquisition of Agile Defense. The deal expands its national-security business, which is expected to approach 10% of company revenue. Agile Defense acquisition
- Negative Sentiment: Fiscal 2027 EPS guidance of $7.50 to $8.00 is below the $8.36 consensus forecast. This earnings outlook shortfall may outweigh the stronger revenue outlook for investors, particularly as management also flagged near-term headwinds. Earnings call highlights
Analyst Upgrades and Downgrades
A number of research firms have issued reports on MMS. Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a research note on Friday, November 13th. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Zacks Research raised shares of Maximus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock has an average rating of “Hold”.
Maximus Stock Performance
The company has a market cap of $3.25 billion, a P/E ratio of 9.16 and a beta of 0.57. The company has a 50 day moving average price of $60.08 and a 200-day moving average price of $62.96. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings data on Thursday, November 19th. The health services provider reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.26. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same period in the previous year, the business earned $1.62 earnings per share. The company’s revenue was down 1.3% on a year-over-year basis. Maximus has set its FY 2027 guidance at 7.500-8.000 EPS. Equities analysts expect that Maximus, Inc. will post 8.03 EPS for the current fiscal year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.32 annualized dividend and a yield of 2.1%. Maximus’s dividend payout ratio (DPR) is presently 19.50%.
Insider Buying and Selling
In other Maximus news, insider Michelle Link sold 3,208 shares of the business’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the sale, the insider directly owned 13,881 shares in the company, valued at approximately $752,766.63. The trade was a 18.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.80% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Empowered Funds LLC purchased a new stake in Maximus in the 2nd quarter worth approximately $504,000. Hsbc Holdings PLC bought a new position in shares of Maximus during the 2nd quarter valued at $956,000. Squarepoint Ops LLC lifted its stake in shares of Maximus by 723.0% in the 2nd quarter. Squarepoint Ops LLC now owns 219,301 shares of the health services provider’s stock valued at $11,790,000 after purchasing an additional 192,655 shares during the last quarter. Corient Private Wealth LP bought a new position in Maximus during the second quarter valued at about $1,984,000. Finally, Reinhart Partners LLC. lifted its position in shares of Maximus by 131.8% in the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock worth $106,575,000 after buying an additional 1,127,346 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.
About Maximus
Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.
Featured Articles
- Five stocks we like better than Maximus
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
